Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study.
Ishikawa E, Yokoyama Y, Chishima H, Kasai H, Kuniyoshi O, Kimura M, Hakamata J, Nakada H, Suehiro N, Nakaya N, Nakajima H, Ikemura S, Kawada I, Yasuda H, Terai H, Jibiki A, Kawazoe H, Soejima K, Muramatsu H, Suzuki S, Nakamura T. Ishikawa E, et al. Among authors: hakamata j. Invest New Drugs. 2023 Feb;41(1):122-133. doi: 10.1007/s10637-023-01328-9. Epub 2023 Jan 13. Invest New Drugs. 2023. PMID: 36637703 Free PMC article.
Development and validation of a new liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of afatinib, dacomitinib, osimertinib, and the active metabolites of osimertinib in human serum.
Ishikawa E, Yokoyama Y, Chishima H, Kuniyoshi O, Sato I, Nakaya N, Nakajima H, Kimura M, Hakamata J, Suehiro N, Nakada H, Ikemura S, Jibiki A, Kawazoe H, Muramatsu H, Suzuki S, Nakamura T. Ishikawa E, et al. Among authors: hakamata j. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 May 30;1199:123245. doi: 10.1016/j.jchromb.2022.123245. Epub 2022 Apr 4. J Chromatogr B Analyt Technol Biomed Life Sci. 2022. PMID: 35436724 Free article.
Lorlatinib-induced visual and auditory hallucinations: A case report.
Hakamata J, Nakada H, Muramatsu H, Masuzawa K, Terai H, Ikemura S, Fukunaga K, Aomori T. Hakamata J, et al. Clin Case Rep. 2021 Apr 7;9(8):10.1002/ccr3.4040. doi: 10.1002/ccr3.4040. eCollection 2021 Aug. Clin Case Rep. 2021. PMID: 34466232 Free PMC article.
Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.
Sakai C, Shimokawa M, Iihara H, Fujita Y, Ikemura S, Hirose C, Kotake M, Funaguchi N, Gomyo T, Imai H, Hakamata J, Kaito D, Minato K, Arai T, Kawazoe H, Suzuki A, Ohno Y, Okura H. Sakai C, et al. Among authors: hakamata j. Oncologist. 2021 Jun;26(6):e1066-e1072. doi: 10.1002/onco.13772. Epub 2021 May 4. Oncologist. 2021. PMID: 33811782 Free PMC article. Clinical Trial.
Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population.
Hashiguchi M, Shimizu M, Hakamata J, Tsuru T, Tanaka T, Suzaki M, Miyawaki K, Chiyoda T, Takeuchi O, Hiratsuka J, Irie S, Maruyama J, Mochizuki M. Hashiguchi M, et al. Among authors: hakamata j. J Pharm Health Care Sci. 2016 Dec 9;2:35. doi: 10.1186/s40780-016-0069-0. eCollection 2016. J Pharm Health Care Sci. 2016. PMID: 27980801 Free PMC article.